Skip to main content
ImmuneCited

Pelargonium sidoides для Acute Bronchitis

A

Meta-analyses demonstrate Pelargonium sidoides (EPs 7630) may significantly reduce bronchitis symptom severity and working inability. Approved as a medicine for respiratory infections in multiple countries. RCT showed working inability decreased to 16% vs 43% in placebo group after 7 days.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dpelargonium\u002Dsidoides\u0026condition\u003Dacute\u002Dbronchitis'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Итог

Meta-analyses demonstrate Pelargonium sidoides (EPs 7630) may significantly reduce bronchitis symptom severity and working inability. Approved as a medicine for respiratory infections in multiple countries. RCT showed working inability decreased to 16% vs 43% in placebo group after 7 days.

Key Study Findings

Other
Research Landscape and Emerging Trends in Herbal Medicine for Pediatric Respiratory Tract Infections: A CiteSpace-Based …
Dose: None или: None Outcome: research landscape of herbal medicine for pediatric RTIs Эффект: None None

Популяция: pediatric patients with respiratory tract infections

Systematic Review
Pelargonium sidoides - from ethnopharmacology to evidence-based medicine: a systematic review.
Dose: None или: None Outcome: clinical efficacy of Pelargonium sidoides for respiratory tract … Эффект: None None

Популяция: patients with acute bronchitis, rhinosinusitis, and tonsillopharyngitis

Randomized Controlled Trial n=240 1 weeks Double-blind
Efficacy and Safety of YJP-40 in Patients with Acute Bronchitis: A Randomized, Double-Blind, Parallel Group …
Dose: None или: Umckamin syrup (P. sidoides extract alone) Outcome: Change in bronchitis severity score (BSS) at day … Эффект: BSS change: -4.31 vs -4.36 non-inferiority demonstrated

Популяция: Patients with acute bronchitis from 7 hospitals

Randomized Controlled Trial 1 weeks Double-blind
Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment …
Dose: Ivy leaf extract + Coptidis rhizome или: Pelargonium sidoides extract Outcome: Bronchitis severity score (BSS) Эффект: None None

Популяция: Adults with acute bronchitis

Review
Chronobiological Efficacy of Combined Therapy of Pelargonium Sidoides and Melatonin in Acute and Persistent Cases …
Dose: None или: None Outcome: inflammation markers Эффект: None None

Популяция: Covid-19

Randomized Controlled Trial n=591 1.0 weeks Open-label
Safety of Pelargonium extract EPs 7630 in young children with acute bronchitis.
Dose: 7.2% или: None Outcome: None Эффект: None None

Популяция: Ab received eps 7630 syrup or solution for 7 days

Key Statistics

8

Исследования

2000

Участники

Positive

A

Оценка

Referenced Papers

Frontiers in pediatrics 2023 7 цитирований
Multidisciplinary respiratory medicine 2023 4 цитирований
Complementary therapies in … 2020 36 цитирований
The Cochrane database … 2013 125 цитирований
Current medical research … 2013 25 цитирований
Phytomedicine : international … 2008 100 цитирований
The Cochrane database … 2008 71 цитирований
Phytomedicine : international … 2007 71 цитирований
Phytomedicine : international … 2007 39 цитирований
Wiener medizinische Wochenschrift … 2007 23 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
30 drops (1.5 mL) liquid extract 3x/day or 20 mg EPs 7630 tablets 3x/day
duration:
7-14 days

Верхний предел: No established UL

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Positive --
None -- Positive --
None 1 weeks Neutral 240
Ivy leaf extract + Coptidis rhizome 1 weeks Positive --
None -- Mixed --
7.2% 1.0 weeks Positive 591
83.6% 10.4 weeks Mixed 505
None -- Positive 2195

Лучшее время приёма: At onset of respiratory symptoms; 3x daily for up to 14 days

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Gastrointestinal discomfort (rare)
  • Allergic skin reactions (rare)
  • Nosebleeds (rare)
  • Hepatotoxicity (very rare, case reports)

Известные взаимодействия

  • Anticoagulants (theoretical increased bleeding risk due to coumarin content)
  • Immunosuppressant medications (may modulate immune function)

Допустимый верхний уровень потребления: No established UL

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Pelargonium sidoides help with Acute Bronchitis?
Based on 8 studies with 2,000 participants, there is strong evidence from multiple clinical trials that Pelargonium sidoides may support Acute Bronchitis management. Our evidence grade is A (Strong Evidence).
How much Pelargonium sidoides should I take for Acute Bronchitis?
Studies have used various dosages. A commonly studied range is 30 drops (1.5 mL) liquid extract 3x/day or 20 mg EPs 7630 tablets 3x/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Pelargonium sidoides?
Reported side effects may include Gastrointestinal discomfort (rare), Allergic skin reactions (rare), Nosebleeds (rare), Hepatotoxicity (very rare, case reports). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Pelargonium sidoides and Acute Bronchitis?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 8 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

Другие ингредиенты для Acute Bronchitis

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.